Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary - PubMed (original) (raw)
Review
. 2007 Sep 15;176(6):532-55.
doi: 10.1164/rccm.200703-456SO. Epub 2007 May 16.
Affiliations
- PMID: 17507545
- DOI: 10.1164/rccm.200703-456SO
Review
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
Klaus F Rabe et al. Am J Respir Crit Care Med. 2007.
Abstract
Chronic obstructive pulmonary disease (COPD) remains a major public health problem. It is the fourth leading cause of chronic morbidity and mortality in the United States, and is projected to rank fifth in 2020 in burden of disease worldwide, according to a study published by the World Bank/World Health Organization. Yet, COPD remains relatively unknown or ignored by the public as well as public health and government officials. In 1998, in an effort to bring more attention to COPD, its management, and its prevention, a committed group of scientists encouraged the U.S. National Heart, Lung, and Blood Institute and the World Health Organization to form the Global Initiative for Chronic Obstructive Lung Disease (GOLD). Among the important objectives of GOLD are to increase awareness of COPD and to help the millions of people who suffer from this disease and die prematurely of it or its complications. The first step in the GOLD program was to prepare a consensus report, Global Strategy for the Diagnosis, Management, and Prevention of COPD, published in 2001. The present, newly revised document follows the same format as the original consensus report, but has been updated to reflect the many publications on COPD that have appeared. GOLD national leaders, a network of international experts, have initiated investigations of the causes and prevalence of COPD in their countries, and developed innovative approaches for the dissemination and implementation of COPD management guidelines. We appreciate the enormous amount of work the GOLD national leaders have done on behalf of their patients with COPD. Despite the achievements in the 5 years since the GOLD report was originally published, considerable additional work is ahead of us if we are to control this major public health problem. The GOLD initiative will continue to bring COPD to the attention of governments, public health officials, health care workers, and the general public, but a concerted effort by all involved in health care will be necessary.
Comment in
- COPD guidelines: the important thing is not to stop questioning.
Fabbri LM, Boschetto P, Mapp CE; Global Initiative for Chronic Obstructive Lung Disease; Global Initiative for Asthma Management and Prevention. Fabbri LM, et al. Am J Respir Crit Care Med. 2007 Sep 15;176(6):527-8. doi: 10.1164/rccm.200706-854ED. Am J Respir Crit Care Med. 2007. PMID: 17823358 No abstract available. - The considerable, often neglected, impact of pulmonary tuberculosis on the prevalence of COPD.
Jung KH, Kim SJ, Shin C, Kim JH. Jung KH, et al. Am J Respir Crit Care Med. 2008 Aug 15;178(4):431; author reply 432-3. doi: 10.1164/ajrccm.178.4.431. Am J Respir Crit Care Med. 2008. PMID: 18676964 No abstract available.
Similar articles
- The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)--why and what?
Vestbo J, Hurd SS, Rodriguez-Roisin R. Vestbo J, et al. Clin Respir J. 2012 Oct;6(4):208-14. doi: 10.1111/crj.12002. Clin Respir J. 2012. PMID: 22906068 Review. - A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD.
Fromer L, Cooper CB. Fromer L, et al. Int J Clin Pract. 2008 Aug;62(8):1219-36. doi: 10.1111/j.1742-1241.2008.01807.x. Epub 2008 Jun 28. Int J Clin Pract. 2008. PMID: 18547365 Review. - The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries.
Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, Vogelmeier CF, Chen R, Mortimer K, Montes de Oca M, Aisanov Z, Obaseki D, Decker R, Agusti A. Halpin DMG, et al. Int J Tuberc Lung Dis. 2019 Nov 1;23(11):1131-1141. doi: 10.5588/ijtld.19.0397. Int J Tuberc Lung Dis. 2019. PMID: 31718748 Review. - Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits.
Lindberg A, Jonsson AC, Rönmark E, Lundgren R, Larsson LG, Lundbäck B. Lindberg A, et al. Respiration. 2005 Sep-Oct;72(5):471-9. doi: 10.1159/000087670. Respiration. 2005. PMID: 16210885
Cited by
- Screening the Best Risk Model and Susceptibility SNPs for Chronic Obstructive Pulmonary Disease (COPD) Based on Machine Learning Algorithms.
Yang Z, Zheng Y, Zhang L, Zhao J, Xu W, Wu H, Xie T, Ding Y. Yang Z, et al. Int J Chron Obstruct Pulmon Dis. 2024 Nov 5;19:2397-2414. doi: 10.2147/COPD.S478634. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 39525518 Free PMC article. - Does adherence to exacerbation action plans matter? Insights from two COPD self-management studies.
Schrijver J, Effing T, van Helden J, van der Palen J, van der Valk P, Brusse-Keizer M, Lenferink A. Schrijver J, et al. Heliyon. 2024 Oct 10;10(20):e39070. doi: 10.1016/j.heliyon.2024.e39070. eCollection 2024 Oct 30. Heliyon. 2024. PMID: 39492899 Free PMC article. - Factors Influencing Prevalence, C-reactive Protein Levels, and Lymphocyte Counts in Chronic Obstructive Pulmonary Disease Patients With Metabolic Syndrome.
Mahato B, Nigoskar S, Lakshmi LJ, Zephy D. Mahato B, et al. Cureus. 2024 Aug 29;16(8):e68122. doi: 10.7759/cureus.68122. eCollection 2024 Aug. Cureus. 2024. PMID: 39347252 Free PMC article. - Assessment of Long-Term Pulmonary Function and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD).
Gabhale SD, Bagrecha MS, Dash M, Sheikh Z, Bhuvaneshwari S, Imran R, Satheesh T. Gabhale SD, et al. J Pharm Bioallied Sci. 2024 Jul;16(Suppl 3):S2737-S2739. doi: 10.4103/jpbs.jpbs_252_24. Epub 2024 Jul 31. J Pharm Bioallied Sci. 2024. PMID: 39346271 Free PMC article. - Frailty, Physical Function Impairment and Pulmonary Function in Aging Men with and without HIV from the Multicenter AIDS Cohort Study (MACS).
Abdo M, Kunisaki KM, Morris A, Stosor V, Chang D, D'Souza G, Crothers K, Abdel-Maksoud M, DiGuiseppi C, Brown TT, MaWhinney S, Erlandson KM. Abdo M, et al. Res Sq [Preprint]. 2024 Sep 10:rs.3.rs-4908040. doi: 10.21203/rs.3.rs-4908040/v1. Res Sq. 2024. PMID: 39315264 Free PMC article. Preprint.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical